MDXH MDxHealth SA

$MDXH . $DVLT,$SIDU., $NLST.,$SPCE . Strong buy 🟩 target 🎯-💲1️⃣ 🚀🚀🚀. 1The report on November 12 is positive. Institutional funds own more than 70% of the shares.☝️

$MDXH Realistic Sale Price Range for MDxHealth: ✅• Pessimistic case: $40–60 million (≈ $0.40–0.65 per share) • Base case: $60–90 million (≈ $0.60–0.95 per share) • Optimistic case: $100–140 million (≈ $1.05–1.45 per share) ✅Potential acquirers (most likely): • Exact Sciences • Myriad Genetics • Labcorp • Quest Diagnostics

$MDXH $qnC $SOuN hey that new uptrender $TmsH is starting Up ☝️and sentiment on stocktwits is 91 extream Bull ❗️Now☝️

$MDXH well I’m in for 150k at $.182 this am. I’ll average down if it moves down. There’s lots of consolidation in the cancer and other testing biz going on right now. $PSNL got bought, $MYGN jjst sold a division today. Likely that $ABT looks to roll its stake in this shitco into a full buyout while prices are beaten down.

$MDXH Capital raise done at 45,4 cents in August, therefore Company should not be worth less imo, 45,4 should have been the floor.

$MDXH I guess we know what the random pump to .66 was, insiders getting out, got to love the corruption

$MDXH The main risk with MDXH relates to the OrbiMed debt facility. MDXH must maintain a $20.0 million minimum cash threshold and meet escalating quarterly trailing twelve-month (TTM) net revenue targets. With cash reserves at $32million, MDXH has a narrow $12million buffer before violating the cash covenant. This risk is also there for the TTM revenue targets. So, it is very hard now to define MDXH true value. Is it 0.40$ or 0.10$ per share... If the numbers are bad, Orbimed will dictate the next steps and the company valuation. I am living in Belgium and have been following MDXH since their initial IPO in Europe. From recent developments, I was convinced they could reach profitability but their last moves have been very bad. Not really sure what to expect now. Good luck to all.

$MDXH What we’re seeing right now is a panic sell. On Monday—or possibly even today, toward the close of the main trading session—there will be a rebound, and a strong one at that, accompanied by buying activity.

$MDXH biggest loser on my watchlist yet again! 😂😂 Longs are going to get destroyed when this trash drops to $.10 next week. It’s coming. Just watch.

$MDXH welp, fuck. Right back where I started loading on Tuesday 😂. Bought some more higher and some more here. 375k shares now. Let’s see how this plays out.

$MDXH ive been following the same thing and paying close attention to the Orbimed covenants. As of now, they arent in violation, but the next two months will be telling. I believe Orbimed is going to pressure them to do a RS before year end as well.

$MDXH insiders are currently locked out to buy off open market until 2 full trading days after quarterly release, which is happening November 12th.

$MDXH this is in fact crazy, given the cash on hand and potential runway still. If i had to guess, this is a financial firm that is liquidating their position. The news doesnt warrant another -65% haircut on the already ridiculously discounted price. They have a pretty substantial liquidity runway. The one looming thing is the 1 dollar share price requirement that i expect theyll ask for an extension on. A reverse split in the next two months isnt ideal.

$MDXH Would LOVE to see some buyers step in at this price level and see some short coverings by end of day with a close over .20. I don't think that is asking for much!

$MDXH I don't know all the specifics of what you all are talking about within this company. However, what I do know is shorts are placing their bets that the company is in dire straights and the price will not go back to mid to high .20's let alone .30-.40's. Borrowing fee has gone up, there are no more short shares available, and as long as this company stays quiet, the price will keep tanking. I've seen this over and over. A R/S is most likely. I'm still holding, but it's not looking good. A recovery would have already happened by now following the 70% drop in the stock post news if buyers felt this company were worth more. Seems to me a dead stock at the moment.

$MDXH Also, extremely telling that insiders have not purchased any shares in this free fall. As of now, there are no Form 4's filed that I can see.

$MDXH Indexes are red that is not helping, holding for now, decent average. I don’t see dilution as they have cash. trade your plan.

$MDXH time for a buyout? With all that cash plus Ip and huge insider ownership I would not rule out, 2 shareholders own 50% os. They bought shares at .45

$MDXH their technology has huge value, don't forget MYRIAD GENETICS Just sold asset to LABCORP for huge amount over 200 mln USD. Earning relese Just coming in a few weeks and updates too... I am quite optimist because worst case scenario priced imo. .34/.40 would be Fair right now imo, price to revenues .20, too low, if 2027 adj ebitda margin and free cash flow confirmed this would be a huge bargain imo. Market cap 20 mln USD, cash and equivalents 32 mln, revenues around 100 mln USD.

$MDXH not sure what this company is up to… they announce upcoming poor earnings ahead of time. And let it bleed like a Chinese scam company. For what purpose…